Graceway Pharmaceuticals. LLC
7Patents
6Active
7Granted
40Portfolio score
Filing activity: Oct 5, 2004 → Oct 13, 2009 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7696159B2 | Treatment for basal cell carcinoma | Human Necessities | 58 | Active |
| US7964612B2 | Therapeutic pyrazolyl thienopyridines | Human Necessities | 2 | Active |
| US7335773B2 | Intermediates for imidazonaphthyridines | Chemistry; Metallurgy | 1 | Expired |
| US7615230B2 | Method for decreasing sebum production | Human Necessities | 1 | Active |
| US7981936B2 | Crystalline ACAT inhibitor | Human Necessities | 0 | Active |
| US7622610B2 | Crystalline ACAT inhibitor | Human Necessities | 0 | Active |
| US7678918B2 | Intermediates for imidazonaphthyridines | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.